Review of current clinical management guidelines for COVID-19 with special reference to India.
Drug Discov Ther
; 14(4): 171-176, 2020.
Article
in English
| MEDLINE | ID: covidwho-745657
ABSTRACT
The healthcare sector has been overwhelmed by the global rise in the number of COVID-19 cases. The primary care physicians at the forefront of this pandemic are being provided with multiple guidelines (state, national, international). The aim of this review was to examine the existing guidelines for congruence and critically analyze them in light of current evidence. A discordance was noted between the national and state guidelines with respect to indication, duration and dosage of antivirals, steroids/immunomodulators, anticoagulation and convalescent plasma. The lack of concordance between various guidelines mandates the need for a unified national guideline that is regularly updated.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Pneumonia, Viral
/
Practice Patterns, Physicians'
/
Practice Guidelines as Topic
/
Coronavirus Infections
/
Betacoronavirus
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Drug Discov Ther
Year:
2020
Document Type:
Article
Affiliation country:
Ddt.2020.03059
Similar
MEDLINE
...
LILACS
LIS